Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Edoxaban in Peripheral Arterial Disease (ePAD)

This study has been completed.
UMC Utrecht
Information provided by (Responsible Party):
Daiichi Sankyo Inc. Identifier:
First received: February 25, 2013
Last updated: November 18, 2015
Last verified: November 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2014
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: November 18, 2015